August 8, 2019

Ambu, Inc. has agreed to pay $3.3 million to resolve its liability under the False Claims Act in connection with allegations that it knowingly sold the government medical supplies that were not in compliance with the Trade Agreements Act (TAA).  Although the TAA only permits government purchases of products from countries with whom the U.S. has a trade agreement, Ambu allegedly sold products from China and Malaysia and falsely certified that they came from compliant countries.  USAO EDPA

Tagged in: Certifications, FCA Federal, Government Procurement Fraud,